CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Adefovir dipivoxil

Last Updated: April 24, 2006
Result type: Reports
Project Number: SR0060-000
Product Line: Reimbursement Review

Generic Name: Adefovir dipivoxil

Brand Name: Hepsera

Manufacturer: Gilead Sciences Canada Inc.

Therapeutic Area: Hepatitis B

Indications: Hepatitis B

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: November 29, 2006

Recommendation Type: Do not list